(88) reported early results that radiotherapy combined with anti PD-1 therapy led to increased T-cell activation and suppression of immunosuppressive pathways, enhancing anti-tumor efficacy in GI- tumors (88). This evidence concerns the gene PDCD1 and neoplasm.